Schizophrenia Overview

Foundational guides to understanding schizophrenia, psychosis, and how the condition affects daily life.

Schizophrenia Overview Psychosis & Episodes Medications Side Effects Famous People with Schizophrenia Patient Experiences CBT for Psychosis Hospitalisation & Crisis Lifestyle & Wellbeing For Families & Caregivers Engineering Schizophrenia Research

Schizophrenia in women: onset, hormones, pregnancy, outcomes

Schizophrenia affects men and women at similar rates over a lifetime, but the timing, hormonal interactions, and life-stage challenges look very different. A practical overview for women and their clinicians.

NMDA receptor hypofunction in schizophrenia

NMDA receptor hypofunction is one of the most testable and best-supported neuroscience models of schizophrenia — and one of the hardest to translate into new drugs.

ICD-11 vs DSM-5: how schizophrenia is classified globally

American psychiatrists use the DSM-5-TR. Most of the rest of the world uses the WHO's ICD-11. Both define schizophrenia — but they emphasise different things.

How is schizophrenia diagnosed? The DSM-5-TR criteria explained

Schizophrenia is diagnosed by a psychiatrist or qualified clinician using the DSM-5-TR or ICD-11 criteria. There is no blood test or brain scan — the diagnosis is clinical.

Schizophrenia vs borderline personality disorder

Up to 30% of people with borderline personality disorder report brief psychotic-like experiences, which can lead to misdiagnosis. Here's what actually separates the two conditions.

Myth: People with schizophrenia can't hold a job

The assumption that schizophrenia rules out employment is wrong. Evidence-based supported employment helps the majority of participants find competitive work.

Genetic counseling for schizophrenia: what families should know

Psychiatric genetic counseling helps families understand inherited risk for schizophrenia honestly — without overpromising or fuelling unnecessary fear.

Dementia vs late-onset psychosis: telling them apart

An older adult with new hallucinations or delusions might have late-onset schizophrenia, a dementia syndrome, delirium, or a medical condition. Sorting it out matters enormously for treatment.

Antipsychotics in adolescents: what families need to know

Several antipsychotics are FDA-approved for adolescents with schizophrenia. Choosing one is a careful, family-centred conversation about benefits, side effects, and monitoring.

Latino communities and schizophrenia care access

Latino Americans with schizophrenia are less likely to be diagnosed early, less likely to receive specialist care, and more likely to face language and immigration barriers — even when insurance is available.

Schizophrenia care in Canada: EPI programs and provincial variability

Canada's universal health system covers schizophrenia treatment, but services vary widely by province. Here's how Early Psychosis Intervention programs and other supports actually work.

Schizophrenia in men: earlier onset, harder course, the data

Men with schizophrenia are typically diagnosed earlier than women and face a slightly more difficult average course. The reasons are not fully understood — but the patterns matter for how care is organised.

What are the early signs of schizophrenia?

Early signs of schizophrenia include social withdrawal, declining performance, sleep changes, and unusual perceptual experiences — usually appearing in the late teens or early twenties.

Schizophrenia vs autism spectrum: overlap and distinctions

Autism and schizophrenia share social withdrawal and unusual perceptions but are distinct neurodevelopmental and psychotic conditions — and they can co-occur in the same person.

Myth: Schizophrenia means low intelligence

Schizophrenia changes how the brain processes information, but it does not reduce a person's underlying intelligence. The relationship is more complex than the stereotype.

Neuroinflammation in schizophrenia: cytokines, microglia, complement

Schizophrenia increasingly looks like a disorder with an immune component. Microglia, complement proteins, and cytokines are now central to research — though many questions remain.

The PANSS (Positive and Negative Syndrome Scale) explained

The PANSS is the rating scale you will see in nearly every schizophrenia drug trial. Here is what each of its 30 items measures and how to read PANSS results in research papers.

The McGorry omega-3 prevention trial: what happened next

A 2010 fish-oil trial suggested omega-3s could prevent psychosis in at-risk young people. A larger replication failed. Here is what the science actually shows now.

Schizophrenia and PTSD: shared symptoms, separate diagnoses

Trauma is common in people with schizophrenia, and PTSD symptoms can mimic — or amplify — psychotic ones. The two conditions need to be addressed together.

Antipsychotics in older adults: dose, monitoring, and the FDA box warning

Antipsychotics in older adults work — but dosing, monitoring, and indication all have to change. The Beers Criteria and FDA boxed warning shape every prescribing decision.

Myth: People with schizophrenia shouldn't have children

The blanket idea that people with schizophrenia shouldn't have children carries echoes of eugenics and is not supported by modern evidence on parenting or genetics.

Asian American communities, schizophrenia, and family stigma

Asian American adults use mental health services at the lowest rate of any major US racial group. The gap is not about lower need — it is about stigma, family expectation, and a workforce that rarely matches the patient.

Schizophrenia care in Australia: headspace, EPPIC, and Medicare

Australia pioneered early intervention in psychosis through EPPIC, built the world's largest youth mental health network in headspace, and funds psychology through Medicare. Here's how the system fits together.

Late-onset schizophrenia: when psychosis emerges after 40

Schizophrenia can begin after 40 — and even after 60. These late-onset presentations are different from textbook young-adult cases and are easily missed. A practical overview.

What's the best medication for schizophrenia? An honest answer

There is no single best antipsychotic for everyone. Clozapine is the most effective overall but is reserved for treatment-resistant cases due to monitoring requirements. The right medication depends on individual response and side-effect tolerability.

Neural oscillations (gamma, theta) in schizophrenia

Brain rhythms coordinate the orchestra of cognition. In schizophrenia, gamma and theta oscillations are altered in ways that link parvalbumin interneuron dysfunction to symptoms.

School accommodations for a teen with schizophrenia

Adolescents with schizophrenia often need real changes to how school works — quieter spaces, flexible deadlines, reduced course loads. Most of these are protected under federal law.

The gut-brain axis in schizophrenia

The gut-brain axis is one of the most intriguing frontiers in schizophrenia research — and one of the most overhyped. Here is what is solid and what is still speculative.

The Brief Psychiatric Rating Scale (BPRS) explained

The BPRS is shorter and older than the PANSS but still widely used. Here is what each of its 18 items captures and how to read BPRS results in your clinic notes.

What is schizophrenia? A plain-language guide

Schizophrenia is a chronic brain condition that affects how a person thinks, feels, and perceives reality — but it is treatable, and recovery is real.